Eagle Bay Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,603
| Closed | -$175K | – | 723 |
|
|
2024
Q4 | $175K | Sell |
6,603
-1,286
| -16% | -$34.1K | 0.11% | 124 |
|
|
2024
Q3 | $228K | Buy |
7,889
+49
| +0.6% | +$1.42K | 0.09% | 154 |
|
|
2024
Q2 | $219K | Buy |
7,840
+647
| +9% | +$18.1K | 0.13% | 112 |
|
|
2024
Q1 | $200K | Buy |
7,193
+1,287
| +22% | +$35.7K | 0.13% | 128 |
|
|
2023
Q4 | $170K | Sell |
5,906
-2,070
| -26% | -$59.6K | 0.11% | 151 |
|
|
2023
Q3 | $265K | Buy |
7,976
+2,540
| +47% | +$84.3K | 0.12% | 113 |
|
|
2023
Q2 | $199K | Sell |
5,436
-3,568
| -40% | -$131K | 0.11% | 127 |
|
|
2023
Q1 | $367K | Sell |
9,004
-1,485
| -14% | -$60.6K | 0.2% | 77 |
|
|
2022
Q4 | $537K | Buy |
10,489
+12
| +0.1% | +$615 | 0.3% | 58 |
|
|
2022
Q3 | $460K | Sell |
10,477
-1,789
| -15% | -$78.5K | 0.28% | 61 |
|
|
2022
Q2 | $643K | Buy |
12,266
+709
| +6% | +$37.2K | 0.39% | 46 |
|
|
2022
Q1 | $598K | Buy |
11,557
+8,929
| +340% | +$462K | 0.49% | 34 |
|
|
2021
Q4 | $155K | Sell |
2,628
-8,012
| -75% | -$473K | 0.1% | 130 |
|
|
2021
Q3 | $459K | Buy |
10,640
+5,172
| +95% | +$223K | 0.26% | 57 |
|
|
2021
Q2 | $217K | Buy |
+5,468
| New | +$217K | 0.17% | 80 |
|